GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » New Ray Medicine International Holding Ltd (HKSE:06108) » Definitions » PB Ratio

New Ray Medicine International Holding (HKSE:06108) PB Ratio : 0.21 (As of May. 17, 2024)


View and export this data going back to 2013. Start your Free Trial

What is New Ray Medicine International Holding PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-17), New Ray Medicine International Holding's share price is HK$0.06. New Ray Medicine International Holding's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.29. Hence, New Ray Medicine International Holding's PB Ratio of today is 0.21.

The historical rank and industry rank for New Ray Medicine International Holding's PB Ratio or its related term are showing as below:

HKSE:06108' s PB Ratio Range Over the Past 10 Years
Min: 0.11   Med: 0.99   Max: 7.58
Current: 0.21

During the past 12 years, New Ray Medicine International Holding's highest PB Ratio was 7.58. The lowest was 0.11. And the median was 0.99.

HKSE:06108's PB Ratio is ranked better than
97.81% of 594 companies
in the Healthcare Providers & Services industry
Industry Median: 2.2 vs HKSE:06108: 0.21

During the past 12 months, New Ray Medicine International Holding's average Book Value Per Share Growth Rate was -8.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -7.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -7.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -16.50% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of New Ray Medicine International Holding was 8.50% per year. The lowest was -34.30% per year. And the median was -7.00% per year.

Back to Basics: PB Ratio


New Ray Medicine International Holding PB Ratio Historical Data

The historical data trend for New Ray Medicine International Holding's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Ray Medicine International Holding PB Ratio Chart

New Ray Medicine International Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.10 1.17 1.12 0.30 0.17

New Ray Medicine International Holding Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.12 0.66 0.30 0.21 0.17

Competitive Comparison of New Ray Medicine International Holding's PB Ratio

For the Pharmaceutical Retailers subindustry, New Ray Medicine International Holding's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Ray Medicine International Holding's PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, New Ray Medicine International Holding's PB Ratio distribution charts can be found below:

* The bar in red indicates where New Ray Medicine International Holding's PB Ratio falls into.



New Ray Medicine International Holding PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

New Ray Medicine International Holding's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.06/0.287
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


New Ray Medicine International Holding  (HKSE:06108) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


New Ray Medicine International Holding PB Ratio Related Terms

Thank you for viewing the detailed overview of New Ray Medicine International Holding's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


New Ray Medicine International Holding (HKSE:06108) Business Description

Traded in Other Exchanges
N/A
Address
19 Dangui Road, B-C, 37th Floor, Dikai International Center, Hangzhou, CHN
New Ray Medicine International Holding Ltd is engaged in the trading of pharmaceutical products in the People's Republic of China. The company's segments include Distribution and trading of pharmaceutical products and Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs, Capsules and Granule drugs, Tablet drugs and Other Drugs. It generates a majority of its revenue from the distribution of Injection Drugs.

New Ray Medicine International Holding (HKSE:06108) Headlines

No Headlines